Atlas Trials

Alzheimer Disease

1,750 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Alzheimer Disease

RecordFirmDate
Yogic Breathing Changes Salivary Components (NCT02108769)Medical University of South Carolina2013-10-01
Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients (NCT03611439)Genescient Corporation2013-10-01
Differential Effects of Various Anesthetic Agents on Cognitive Function in Patients With Alzheimer's Disease (NCT01870453)Massachusetts General Hospital2013-10-01
Alzheimer's Disease Imaging With PET/MRI - Beta-amyloid (NCT02343757)University Hospitals Cleveland Medical Center2013-10-01
Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly (NCT01951118)New York State Psychiatric Institute2013-10-01
Impact of Physical Activity on Successful Aging (NCT03034746)Universita di Verona2013-09-01
Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects (NCT04474405)Avid Radiopharmaceuticals2013-08-16
Retinal Nerve Fiber Layer Thickness and Cerebrospinal Fluid Aβ/Tau (NCT03447613)Shanghai 10th People's Hospital2013-08-01
New CSF Biomarkers for Alzheimer's Disease (NCT03621839)Central Hospital, Nancy, France2013-07-12
Neuroelectrical Biomarkers for Alzheimer's Disease Stages (NCT01880151)Institut National de la Santé Et de la Recherche Médicale, France2013-07-12
24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion (NCT02361242)Pharnext S.C.A.2013-06-01
Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease (NCT01819714)Centre Hospitalier Universitaire de Nīmes2013-06-01
A Study of LY3002813 in Participants With Alzheimer's Disease (NCT01837641)Eli Lilly and Company2013-05-03
Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease (NCT01850238)Axon Neuroscience SE2013-05-01
Transcranial Direct Current Stimulation (tDCS) as a Cognitive Enhancer for Patients With Alzheimers Disease (NCT02518412)University of Tromso2013-05-01
Effects of Exercise on Cognitive Performance of Patients With Alzheimer-type Dementia. Pilot Study. (NCT02195596)Basque Health Service2013-04-01
A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects (NCT01860625)Icure Pharmaceutical Inc.2013-04-01
Self-consciousness in Dementia (NCT01782248)University Hospital, Strasbourg, France2013-03-13
A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease (NCT01807026)Eli Lilly and Company2013-03-01
Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD) (NCT02361424)Pharnext S.C.A.2013-02-01
ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE (NCT01772095)Elpen Pharmaceutical Co. Inc.2013-02-01
Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI) (NCT02819700)Centre Hospitalier Universitaire, Amiens2013-01-29
A Trial to Support Caregivers of Patients With Dementia in Italy: the UP-TECH Project (NCT01700556)Istituto Nazionale di Ricovero e Cura per Anziani2013-01-14
Olfactory Neuroepithelial Tissue of Alzheimer Disease (NCT02129452)Seoul National University Hospital2013-01-01
Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of Life (NCT01796314)University Hospital, Toulouse2013-01-01
Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural Units (NCT01901263)Centre Hospitalier Universitaire de Saint Etienne2012-10-01
The Protective Effect of Omega-3 Fatty Acid on Cognitive Function Among Patients With Mild Dementia (NCT04972643)Taichung Veterans General Hospital2012-09-23
Vanderbilt Memory and Aging Project (NCT05372159)Vanderbilt University Medical Center2012-09-17
Predicting the Conversion From Mild Cognitive Impairment to Dementia (NCT01823666)Dongzhimen Hospital, Beijing2012-09-01
Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study (NCT01582919)University Hospital, Bordeaux2012-09-01
Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease (NCT01680588)Navidea Biopharmaceuticals2012-08-01
Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia (NCT02702817)Douglas Mental Health University Institute2012-08-01
Ability to Drive of Early Stage Alzheimer Disease (NCT01566071)CHU de Reims2012-07-01
Volunteers Adding Life in Dementia (NCT01646723)Queen's University2012-06-01
ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease (NCT01608061)Functional Neuromodulation Ltd2012-05-01
Clinical Evaluation of Florbetapir in Primary Progressive Aphasia (NCT04726527)University of Chicago2012-03-15
The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD (NCT01696591)Duk Lyul Na2012-03-01
Biomarker Study to Diagnose Alzheimer's Disease (NCT01874418)Seoul National University Hospital2012-03-01
Biological Sample Collection for Research and Biobanking (NCT04270604)New York Stem Cell Foundation Research Institute2012-02-06
Erythrocyte Complement Receptor 1 and Alzheimer Disease (NCT01565434)CHU de Reims2012-02-01
Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism Investigation (NCT01378026)China Medical University Hospital2012-01-01
Effect of Physical Exercise in Alzheimer Patients (NCT01681602)Rigshospitalet, Denmark2012-01-01
Imaging of New Learning in Severe Alzheimer's Disease Patients (NCT01839422)University Hospital, Caen2012-01-01
Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development (NCT01487395)University Hospital, Lille2011-12-01
BRINK (BRain In Kidney Disease) Memory Study 2.0 (NCT04975464)Anne Murray2011-11-15
Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia (NCT02675270)Georgetown University2011-11-01
Web-based Psycho-Educational Program to Support Carers of Alzheimer's Patients (NCT01430286)Assistance Publique - Hôpitaux de Paris2011-10-01
Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease (NCT01453569)Shanghai Greenvalley Pharmaceutical Co., Ltd.2011-10-01
Alzheimer's Disease - Input of Vitamin D With mEmantine Assay (NCT01409694)University Hospital, Angers2011-09-01
A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease (NCT01436188)Janssen Research & Development, LLC2011-09-01
Olfactory Deficits in Neurologic Disease (NCT05019014)Massachusetts General Hospital2011-08-10
Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls (NCT01461109)Institute for Neurodegenerative Disorders2011-08-01
Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient Care (NCT01639586)Department of Clinical Research and Innovation2011-08-01
Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans (NCT01550549)Avid Radiopharmaceuticals2011-08-01
Tai Chi 6-Form Sports Apparatus With Alzheimer's Disease (NCT02978768)Chang Gung Memorial Hospital2011-08-01
Patients With Alzheimer Disease, Spouse Carers and Risk of Institutionalization: a Prospective Observational Cohort Study of Dyads (AID Study) (NCT02351453)University Hospital, Angers2011-08-01
Conservation of Praxis in the Food and Alzheimer Disease (NCT01743534)University Hospital, Limoges2011-07-01
Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls (NCT01348061)KineMed2011-07-01
Transcranial Magnetic Stimulation (TMS) Treatment for Alzheimer Patients (NCT01334450)Hadassah Medical Organization2011-06-01
Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and Actigraphy (NCT01384344)Centre Hospitalier Universitaire de Nice2011-06-01
Therapeutic Effect of Direct Current Stimulation on Cognitive Function of Mild to Moderate Alzheimer Patients (NCT01746498)Assiut University2011-06-01
The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease (NCT01181921)Janssen-Cilag, S.A.2011-05-01
Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease (NCT03136679)Baylor Research Institute2011-03-22
Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) Dynamics (NCT01194713)University Medical Center Nijmegen2011-03-01
Isotopic Imaging for Prodromal Alzheimer's Disease (NCT01231295)Centre Hospitalier Universitaire de Nīmes2011-02-01
Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers (NCT01273272)University of Zurich2011-02-01
Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine (NCT01696123)Shahid Beheshti University of Medical Sciences2011-01-01
Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease. (NCT00938665)Neuronetrix, Inc.2010-12-01
Sleep Apnea in Early to Mid-Stage Alzheimer's Disease (NCT01400542)Centre Hospitalier Universitaire de Saint Etienne2010-12-01
Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F) (NCT02149017)Seoul National University Hospital2010-12-01
Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HC (NCT01268020)Institute for Neurodegenerative Disorders2010-12-01
Truncated and Extended Forms of Amyloid Beta Peptides in Alzheimer's Disease: Genesis, Toxicity and Identification as Biological Markers (NCT01128725)Centre Hospitalier Universitaire de Nice2010-09-01
Prospective Memory Imaging (NCT01638884)University Hospital, Caen2010-09-01
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558 (NCT01217021)Institute for Neurodegenerative Disorders2010-09-01
Drug-Drug Interaction Study With Rifampin (NCT01002079)Bristol-Myers Squibb2010-08-01
Assessment of Sleep Disturbance in Alzheimer Disease (NCT00831298)Centre Hospitalier Universitaire de Nice2010-07-01
Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients (NCT01183806)Federal University of Bahia2010-07-01
Neuro Imaging and Multimodal Alzheimer's Disease (NCT02839187)University Hospital, Toulouse2010-06-01
Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio) (NCT01314638)University Hospital, Angers2010-05-01
Eye Movement Recording as an Early Differential Diagnostic Tool for Alzheimer/Depression (NCT01434940)Centre Hospitalier Universitaire de Besancon2010-04-01
Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions (NCT01209156)Institute for Neurodegenerative Disorders2010-03-01
Multiple Dose Japanese Bridging Study (NCT01057030)Bristol-Myers Squibb2010-03-01
Comparison of 3 Learning Methods to Improve Independent Activities of Daily Living (IADLs) in Alzheimer Disease (NCT01095718)Department of Clinical Research and Innovation2010-03-01
Alzheimer's Disease Acitretin Medication (NCT01078168)K. Lieb2010-03-01
Cerebro Spinal Fluid Collection (CSF) (NCT04844060)University Hospital, Strasbourg, France2010-02-01
Physical Exercise as an Additional Treatment for Alzheimer Disease (NCT01515982)Universidade Federal do Rio de Janeiro2010-02-01
Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease (NCT01094145)University of Cologne2010-01-01
TMS Stimulation and Cognitive Training in Alzheimer Patients (NCT01168245)Neuronix Ltd2010-01-01
Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER) (NCT01039194)Bristol-Myers Squibb2010-01-01
A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients (NCT00998764)Pfizer2009-12-01
Clinical Evaluation of Florbetapir F 18 (18F-AV-45) (NCT01518374)Avid Radiopharmaceuticals2009-12-01
A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients (NCT00996918)Pfizer2009-12-01
To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients (NCT01023685)Novartis2009-12-01
Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease (NCT00955409)Pfizer2009-11-05
Supporting Caregivers of Persons With Dementia: A Pilot Study (NCT00908492)McMaster University2009-11-01
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions (NCT01028209)Institute for Neurodegenerative Disorders2009-11-01
Gait and Alzheimer Interaction Tracking (GAIT) Study (NCT01315717)University Hospital, Angers2009-11-01
A Longitudinal Multidimensional Population Study on Brain Aging (NCT01345110)Fondazione Golgi Cenci2009-11-01
Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology (NCT01020838)Lantheus Biosciences Ltd.2009-11-01
Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease (NCT01001637)Jaslok Hospital and Research Centre2009-10-01
← Previous Next →

Track Alzheimer Disease automatically

Every clearance here is in the API, with alerts when new ones post.